Population Pharmacokinetic/Pharmacodynamic Modeling of Tacrolimus in Renal Transplant Recipients: Impact of CYP3A5 Genotype and Wuzhi Capsule Co-Medication. [PDF]
Xiang Q +6 more
europepmc +1 more source
Correction to "Genotype-Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers". [PDF]
europepmc +1 more source
Impact of <i>CYP1A</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, <i>CYP3A4</i>, <i>CYP3A5</i>, and <i>NFIB</i> genotypes on clozapine serum concentration in smokers and nonsmokers. [PDF]
Lenk HÇ +3 more
europepmc +1 more source
Recipient Versus Donor CYP3A4/5 Genotypes in Adult Liver Transplant Recipients to Achieve Therapeutic Tacrolimus Concentrations Early Post-Transplant. [PDF]
Eken E +7 more
europepmc +1 more source
Impact of CYP3A4 and CYP3A5 polymorphisms on tacrolimus dose requirements in Saudi kidney transplant patients. [PDF]
Al Nasser MS +8 more
europepmc +1 more source
Hidden in Plain Sight: Low Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality. [PDF]
Süsal C +4 more
europepmc +1 more source
Pharmacogenetics Approach for Personalized Tacrolimus Dosing in Heart Transplantation: A Case Report and Literature Review. [PDF]
Nikpalj N +5 more
europepmc +1 more source
The application of genetic testing technology in kidney transplantation: precision matching, non-invasive monitoring and personalized management. [PDF]
Zhang Y +5 more
europepmc +1 more source
Clinical-oriented tacrolimus dosing algorithms in kidney transplant based on genetic algorithm and deep forest. [PDF]
Min J +5 more
europepmc +1 more source
Case Report: Life-threatening cisplatin-induced myelosuppression in pediatric osteosarcoma: molecular mechanisms, pharmacogenomic profiling, and targeted clinical management. [PDF]
Dai C, Zhang Y, Zhang Y, Dong Y.
europepmc +1 more source

